Skip to main content
SpringerLink
Log in
Book cover

The Hepatitis C Viruses pp 327–339Cite as

Strategies and Prospects for Vaccination Against the Hepatitis C Viruses

  • Chapter

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 242))

Abstract

In the USA, it has been shown that much of the hepatitis C virus (HCV)-associated disease burden arose from transmission through recreational drug use in which contaminated needles or syringes (or possibly cocaine straws; CONRY-CANTILENA et al. 1996) are shared (ALTER 1993). Currently, roughly 30,000 newly acquired acute HCV infections occur annually in the USA, most of which have intravenous drug use as the risk factor (ALTER 1993). However, in the remaining cases, multiple sexual partners remains an identified risk factor as does any activity subjecting the individual to exposure to contaminated blood (e.g. health-care workers, dialysis patients, organ recipients etc.; ALTER 1993). Therefore, while a prophylactic HCV vaccine would probably be used in high-risk groups initially, there would be a case for implementing universal vaccination of children (as in the case for the HBV vaccine) in order to prevent infection associated with adult activities. While there are similarities in the epidemiology of HCV between the USA and other developed countries, it appears that many developing countries suffer from a huge incidence of HCV infection due to past use of nondisposable injection needles/syringes in medical practices as well as cultural practices involving blood transfer. In these situations, public health measures and education programs are of paramount importance.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams G, Kuntz S, Rabalais G, Bratcher D, Tamburro CH et al. (1997) Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children. Pediatr Infect Dis J 16:533–534

    Article  PubMed  CAS  Google Scholar 

  • Allander T, Beyene A, Jacobson SH, Grillner L, Persson MAA (1997) Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response. J Infect Dis 175:26–31

    Article  PubMed  CAS  Google Scholar 

  • Alter HJ (1989) Chronic consequences of non-A, non-B hepatitis. In: Seef LB, Lewis JH (eds) Current prospective in hepatology. Plenum, New York, pp 83–97

    Google Scholar 

  • Alter M J (1993) The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 2:155–166

    PubMed  CAS  Google Scholar 

  • Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A et al. (1995) Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 69:2462–2470

    PubMed  CAS  Google Scholar 

  • Baumert TF, Ito S, Wong DT, Liang TJ (1998) Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 72:3827–3836

    PubMed  CAS  Google Scholar 

  • Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T (1994) Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 331:1607–1611

    Article  PubMed  CAS  Google Scholar 

  • Botarelli P, Brunetto MR, Minutello MA et al. (1993) T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104:580–587

    PubMed  CAS  Google Scholar 

  • Boyle JS, Brady JL, Lew AM (1998) Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408–411

    Article  PubMed  CAS  Google Scholar 

  • Bruna-Romero O, Lasarte J J, Wilkinson G, Grace K, Clarke B et al. (1997) Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology 25:470–477

    Article  PubMed  CAS  Google Scholar 

  • Bukh J, Emerson SU, Purcell RH (1997) Genetic heterogeneity of hepatitis C virus and related viruses. In: Rizzetto M, Purcell RH, Gerin JL, Verme G (eds) Viral hepatitis and liver disease. Edizioni Minerva Medica, Torino, pp 167–175

    Google Scholar 

  • Bukh J, Purcell RH, Miller RH (1993) At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide. Proc Natl Acad Sci USA 90:8234–8238

    Article  PubMed  CAS  Google Scholar 

  • Bukh J, Purcell RH, Miller RH (1994) Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 91:8239–8243

    Article  PubMed  CAS  Google Scholar 

  • Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA et al. (1995) Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521–530

    Article  PubMed  CAS  Google Scholar 

  • Chen C-M, You L-R, Hwang L-H, Wu Lee Y-H (1997) Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-ß receptor modulates the signal pathway of the lymphotoxin-ß receptor. J Virol 71:9417–9426

    PubMed  CAS  Google Scholar 

  • Chien DY, Choo Q-L, Ralston R, Spaete R et al. (1993) Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933

    Article  PubMed  CAS  Google Scholar 

  • Choo Q-L, Kuo G, Ralston R et al. (1994) Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 91:1294–1298

    Article  PubMed  CAS  Google Scholar 

  • Choo Q-L, Richman KH, Han JH et al. (1991) Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451–2455

    Article  PubMed  CAS  Google Scholar 

  • Christie JML, Healey CJ, Watson J, Wong VS, et al. (1997) Clinical outcome of hypo- gammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow-up. Clin Exp Immunol 110:4–8

    Article  PubMed  CAS  Google Scholar 

  • Conry-Cantilena C, Vanraden M, Gibble J, Melpoler J, Shakil AO et al. (1996) Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691–1696

    Article  PubMed  CAS  Google Scholar 

  • Cooper S, Erickson AL, Adams EJ, Kansspan J, Weiner AJ et al. (1999) Analysis of a successful immune response against hepatitis C virus. Immunity 10:439–449

    Article  PubMed  CAS  Google Scholar 

  • Deleersnyder V, Pillez A, Wychowski C, Blight K, Xu J et al. (1997) Formation of native hepatitis C virus glycoprotein complexes. J Virol 71:697–704

    PubMed  CAS  Google Scholar 

  • Diepolder HM, Gerlach J-T, Zachoval R, Hoffman RM, Jung M-C et al. (1997) Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71:6011–6019

    PubMed  CAS  Google Scholar 

  • Diepolder HM, Zachoval R, Hoffman RM, Wierenga EA, Santantonio T et al. (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007

    Article  PubMed  CAS  Google Scholar 

  • Donelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW et al. (1995) Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1:583–587

    Article  Google Scholar 

  • Driver DA, Polo JM, Belli BA, Banks TA, Mangala H, Dubensky TW Jr (1998) Plasmid DNA-based alphavirus expression vectors for nucleic acid immunization. Mol Ther 1:510–520

    CAS  Google Scholar 

  • Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM (1994) Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68:6147–6160

    PubMed  CAS  Google Scholar 

  • Farci P, Alter HJ, Govindarajan S et al. (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135–140

    Article  PubMed  CAS  Google Scholar 

  • Farci P, Shimoda A, Wong D, Cabezón T, De Gioannis D et al. (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 93:15394–15399

    Article  PubMed  CAS  Google Scholar 

  • Féray C, Gigai M, Samuel D, Ducot B, Maissonneuve P et al. (1998) Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 128:810–816

    PubMed  Google Scholar 

  • Geissler M, Gesien A, Tokushige K, Wands JR (1997) Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine- expressing plasmids. J Immunol 158:1231–1237

    PubMed  CAS  Google Scholar 

  • Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K (1991) Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547–5551

    Article  PubMed  CAS  Google Scholar 

  • Houghton M, Choo Q-L, Chien D, Kuo G, Weiner A et al. (1997) Development of an HCV vaccine. In: Rizzetto M, Purcell RH, Gerin JL, Verme G (eds) Viral hepatitis and liver disease. Edizioni Minerva Medica, Torino, pp 656–659

    Google Scholar 

  • Inchauspé G, Major ME, Nakano I, Vitvitski L, Trépo C (1997) DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine 15:853–856

    Article  PubMed  Google Scholar 

  • Ishii K, Rosa D, Watanabe Y, Katayama T, Harada H et al. (1998) High titers of envelope neutralizing antibodies correlate with natural resolution of chronic hepatitis C. Hepatology (in press).

    Google Scholar 

  • Kato N, Ootsuyama Y, Sekiya H et al. (1994) Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 68:4776–4784

    PubMed  CAS  Google Scholar 

  • Kikughi K, Tateda A (1980) A trial for prevention of serum hepatitis with intravenous human gammaglobulin (venoglobulin). J Jpn Soc Blood Transfus 24:2–8

    Google Scholar 

  • Kita H, Moriyama T, Kaneko T et al. (1993) HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039–1044

    PubMed  CAS  Google Scholar 

  • Knodell RG, Conrad ME, Ginsberg AL, Bell CJ (1976) Efficacy of prophylactic gamma-globulin in preventing non-A, non-B posttransfusion hepatitis. Lancet 1:557–561

    Article  PubMed  CAS  Google Scholar 

  • Knodell RG, Conrad NE, Ishak KG (1977) Development of chronic liver disease after acute non-A, non- B post-transfusion hepatitis: role of gamma globulin prophylaxis in its prevention. Gastroenterology 72:902–909

    PubMed  CAS  Google Scholar 

  • Kobayashi M, Tanaka E, Matsumoto A, Ichijo T, Kiyosawa K (1997) Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C. J Gastroenterol Hepatol 12:73–76

    Article  PubMed  CAS  Google Scholar 

  • Krawczynski K, Alter M J, Tankersley DL et al. (1993) Studies on protective efficacy of hepatitis C immunoglobulins (HCIG) in experimental hepatitis C virus infection. Hepatology 18:110

    Article  Google Scholar 

  • Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R (1995) Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 69:5859–5863

    PubMed  CAS  Google Scholar 

  • Lai ME, Mazzoleni AP, Argiolu F, Virgilis SD, Balesterieri A et al. (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343:388–390

    Article  PubMed  CAS  Google Scholar 

  • Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G et al. (1996) T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti- hepatitis C virus-positive blood donors without viremia. Hepatology 24:790–795

    PubMed  CAS  Google Scholar 

  • Lechner S, Rispeter K, Meisel H, Kraas W, Jung G et al. (1998) Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology 243:313–321

    Article  PubMed  CAS  Google Scholar 

  • Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT (1995) Genetic immunization against herpes simplex virus: Protection is mediated by CD4+ T lymphocytes. J Immunol 155:259–265

    PubMed  CAS  Google Scholar 

  • Martell M, Esteban JI, Quer J et al. (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225–3229

    PubMed  CAS  Google Scholar 

  • Martins LP, Lau LL, Asano MS, Ahmed R (1995) DNA vaccination against persistent viral infection. J Virol 69:2574–2582

    PubMed  CAS  Google Scholar 

  • Matsumoto M, Hsieh T-Y, Zhu N, vanArsdale T, Hwang AB et al. (1997) Hepatitis C virus interacts with the cytoplasmic tail of lymphotoxin-ß receptor. J Virol 71:1301–1309

    PubMed  CAS  Google Scholar 

  • Michalak J-P, Wychowski C, Choukhi A, Meunier J-C, Ung S et al. (1997) Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 78:2299–2306

    PubMed  CAS  Google Scholar 

  • Minutello MA, Pileri P, Unutmaz et al. (1993) Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 178:17–25

    Article  PubMed  CAS  Google Scholar 

  • Missale G, Bertoni R, Lamonaca V, Valli A, Massari M et al. (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98:706–714

    Article  PubMed  CAS  Google Scholar 

  • Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K et al. (1997) Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78:1527–1531

    PubMed  CAS  Google Scholar 

  • Nakano I, Maertens G, Major ME, Vitvitski L, Dubuisson J et al. (1997) Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol 71:7101–7109

    PubMed  CAS  Google Scholar 

  • Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J et al. (1997) The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 158:1473–1481

    PubMed  CAS  Google Scholar 

  • Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JYN (1998) Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 28:225–230

    Article  PubMed  CAS  Google Scholar 

  • Ogata N, Alter HJ, Miller RH, Purcell RH (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 88:3392–3396

    Article  PubMed  CAS  Google Scholar 

  • Piazza M, Sagliocca L, Tosone G, Guadagnino V, Stazi MA et al. (1997) Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. Arch Intern Med.157:1537–1544.

    Article  PubMed  CAS  Google Scholar 

  • Prince AM, Brotman B, Huima T, Pascual D, Jaffery M et al. (1992) Immunity in hepatitis C infection. J Infect Dis 165:438–443

    Article  PubMed  CAS  Google Scholar 

  • Ralston R, Thudium K, Berger K et al. (1993) Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 67:6753–6761

    PubMed  CAS  Google Scholar 

  • Ray RB, Lagging LM, Meyer K, Steele R, Ray R (1995) Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 37:209–220

    Article  PubMed  CAS  Google Scholar 

  • Ray RB, Lagging LM, Meyer K, Ray R (1996a) Hepatitis C virus core protein cooperates with ras and transform primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70:4438–4443

    PubMed  CAS  Google Scholar 

  • Ray RB, Meyer K, Ray R (1996b) Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176–182

    Article  PubMed  CAS  Google Scholar 

  • Ray RB, Steele R, Meyer K, Ray R (1997) Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272:10983–10986

    Article  PubMed  CAS  Google Scholar 

  • Rehermann B, Chang K-M, McHutchison J, Kokka R, Houghton M et al. (1996a) Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70:7092–7102

    PubMed  CAS  Google Scholar 

  • Rehermann B, Chang K-M, McHutchison JG, Kokka R, Houghton M, Chisari FV (1996b) Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432–1440

    Article  PubMed  CAS  Google Scholar 

  • Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L et al. (1996) A quantitative test to estimate neutralising antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 93:1759–1763

    Article  PubMed  CAS  Google Scholar 

  • Ruggieri A, Harada T, Matsuura Y, Miyamura T (1997) Sensitization to fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68–76

    Article  PubMed  CAS  Google Scholar 

  • Sakamuro D, Furukawa T, Takegami T (1995) Hepatitis C virus nonstructural protein NS3 transforms NIH3T3 cells. J Virol 69:3893–3896

    PubMed  CAS  Google Scholar 

  • Sanchez-Quijano A, Lisen E, Diaz-Torres MA, Rivera F, Pineda JA et al. (1988) Prevention of posttransfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1:1245–1249

    Article  PubMed  CAS  Google Scholar 

  • Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH et al. (1994) Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68:1494–1500

    PubMed  CAS  Google Scholar 

  • Simmonds P, Mellor J, Nuchprayoon C, Tanprasert S, Smith DB (1997) Molecular epidemiology and classification of variants of hepatitis C virus found in South East Asia. In: Rizzetto M, Purcell RH, Gerin JL, Verme G (eds) Viral hepatitis and liver disease. Edizioni Minerva Medica, Torino, pp 187–194

    Google Scholar 

  • Spaete RR, Alexander D, Rugroden ME et al. (1992) Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188:819–830

    Article  PubMed  CAS  Google Scholar 

  • Tang D, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356:152–154

    Article  PubMed  CAS  Google Scholar 

  • Thomssen R, Bonk S, Propfe C, Heermann K-H, Kochel HG et al. (1992) Association of hepatitis C virus in human sera with ß-lipoprotein. Med Microbiol Immunol 181:293–300

    Article  PubMed  CAS  Google Scholar 

  • Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB et al. (1996) Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24:14–20

    Article  PubMed  CAS  Google Scholar 

  • Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Kuo GC (1997) Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25:449–458

    Article  PubMed  CAS  Google Scholar 

  • Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749

    Article  PubMed  CAS  Google Scholar 

  • Wang B, Merva M, Dang K, Ugen KE, Boyer J et al. (1994) DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. AIDS Res Hum Retroviruses 4:S35

    Google Scholar 

  • Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E et al. (1995) Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 92:2755

    Article  PubMed  CAS  Google Scholar 

  • Weiner AJ, Geysen HM, Christopherson C et al. (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 89:3468–3472

    Article  PubMed  CAS  Google Scholar 

  • Williams WV, Boyer JD, Merva M, Livolsi V, Wilson B et al. (1993) Genetic infection induces protective in vivo immune responses. DNA Cell Biol 12:675–683

    Article  PubMed  CAS  Google Scholar 

  • Wolff JA, Malone RW, Williams P, Chong W, Acsadi G et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468

    Article  PubMed  CAS  Google Scholar 

  • Wong DKH, Dudley DD, Afdhal NH, Dienstag J, Rice CM et al. (1998) Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 160:1479–1488

    PubMed  CAS  Google Scholar 

  • Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Erti HC (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132–140

    Article  PubMed  CAS  Google Scholar 

  • Yokoyama M, Zhang J, Whitton JL (1995) DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 69:2684–2688

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chiron Corporation, 4560 Horton Street, Office 4.3138, Emeryville, CA, 94608, USA

    M. Houghton

Authors
  1. M. Houghton
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Digestive Diseases and Genetics — Winship Cancer Center, Emory University School of Medicine, 1639 Pierce Drive, Rm 2101 WMRB, 30322, Atlanta, GA, USA

    Curt H. Hagedorn M.D.

  2. Department of Molecular Microbiology, Washington University School of Medicine, 600 South Euclid Avenue, 63110, St. Louis, MO, USA

    Charles M. Rice M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Houghton, M. (2000). Strategies and Prospects for Vaccination Against the Hepatitis C Viruses. In: Hagedorn, C.H., Rice, C.M. (eds) The Hepatitis C Viruses. Current Topics in Microbiology and Immunology, vol 242. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59605-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59605-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64047-6

  • Online ISBN: 978-3-642-59605-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation